JP2018512431A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512431A5
JP2018512431A5 JP2017553132A JP2017553132A JP2018512431A5 JP 2018512431 A5 JP2018512431 A5 JP 2018512431A5 JP 2017553132 A JP2017553132 A JP 2017553132A JP 2017553132 A JP2017553132 A JP 2017553132A JP 2018512431 A5 JP2018512431 A5 JP 2018512431A5
Authority
JP
Japan
Prior art keywords
less
units
unit
parent
antibody species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017553132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512431A (ja
JP6962819B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/026620 external-priority patent/WO2016164708A1/en
Publication of JP2018512431A publication Critical patent/JP2018512431A/ja
Publication of JP2018512431A5 publication Critical patent/JP2018512431A5/ja
Application granted granted Critical
Publication of JP6962819B2 publication Critical patent/JP6962819B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017553132A 2015-04-10 2016-04-08 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法 Active JP6962819B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562146116P 2015-04-10 2015-04-10
US62/146,116 2015-04-10
US201562249180P 2015-10-30 2015-10-30
US62/249,180 2015-10-30
PCT/US2016/026620 WO2016164708A1 (en) 2015-04-10 2016-04-08 Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020080220A Division JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Publications (3)

Publication Number Publication Date
JP2018512431A JP2018512431A (ja) 2018-05-17
JP2018512431A5 true JP2018512431A5 (cg-RX-API-DMAC7.html) 2019-05-09
JP6962819B2 JP6962819B2 (ja) 2021-11-05

Family

ID=57072068

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017553132A Active JP6962819B2 (ja) 2015-04-10 2016-04-08 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2020080220A Active JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2021085111A Pending JP2021119207A (ja) 2015-04-10 2021-05-20 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020080220A Active JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2021085111A Pending JP2021119207A (ja) 2015-04-10 2021-05-20 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Country Status (6)

Country Link
US (2) US10787500B2 (cg-RX-API-DMAC7.html)
EP (1) EP3280444B1 (cg-RX-API-DMAC7.html)
JP (3) JP6962819B2 (cg-RX-API-DMAC7.html)
CN (1) CN108472360B (cg-RX-API-DMAC7.html)
AU (2) AU2016245887B2 (cg-RX-API-DMAC7.html)
WO (1) WO2016164708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101463631B1 (ko) 2006-03-31 2014-11-19 추가이 세이야쿠 가부시키가이샤 항체의 혈중 동태를 제어하는 방법
RU2510400C9 (ru) 2007-09-26 2014-07-20 Чугаи Сейяку Кабусики Кайся Способ модификации изоэлектрической точки антитела с помощью аминокислотных замен в cdr
EP3825326A1 (en) * 2014-04-01 2021-05-26 Adimab, LLC Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
WO2016159213A1 (ja) 2015-04-01 2016-10-06 中外製薬株式会社 ポリペプチド異種多量体の製造方法
CN108472360B (zh) 2015-04-10 2023-01-17 阿迪马布有限责任公司 从亲代同源二聚抗体种类中纯化异源二聚多特异性抗体的方法
JP6954842B2 (ja) 2015-12-25 2021-10-27 中外製薬株式会社 増強された活性を有する抗体及びその改変方法
BR112018009312A8 (pt) 2015-12-28 2019-02-26 Chugai Pharmaceutical Co Ltd método para promover eficiência de purificação de polipeptídeo contendo região de fc
CA3016301A1 (en) 2016-04-28 2017-11-02 Chugai Seiyaku Kabushiki Kaisha Antibody-containing preparation
MY209831A (en) 2016-09-06 2025-08-07 Chugai Pharmaceutical Co Ltd Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coagulation factor ix and coagulation factor x and/or activated coagulation factor x
SG11202003833TA (en) * 2017-11-01 2020-05-28 Chugai Pharmaceutical Co Ltd Antibody variant and isoform with lowered biological activity
MY207066A (en) * 2018-08-17 2025-01-28 Regeneron Pharma Method and chromatography system for determining amount and purity of a multimeric protein
JP2022501357A (ja) * 2018-09-21 2022-01-06 テネオバイオ， インコーポレイテッド ヘテロ二量体多重特異性抗体を精製するための方法
US11022585B2 (en) 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
CN114539416B (zh) * 2020-11-26 2024-11-08 盛禾(中国)生物制药有限公司 一种双特异性抗体的层析纯化工艺

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459004A (en) 1891-09-08 Box for steaming cops
US231A (en) 1837-06-10 Stove for heating irons for the use of tailors
US8188A (en) 1851-07-01 Htkstaht
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
WO1991015581A1 (en) 1990-04-05 1991-10-17 Roberto Crea Walk-through mutagenesis
US5492817A (en) 1993-11-09 1996-02-20 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
US5665563A (en) 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
ES2097363T3 (es) 1991-10-11 1997-04-01 Promega Corp Transcripcion y traduccion acopladas en un extracto exento de celulas eucariotas.
US20030036092A1 (en) 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5866344A (en) 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6828422B1 (en) 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US6165718A (en) 1996-01-10 2000-12-26 Novo Nordisk A/S Novo Alle Method for in vivo production of a mutant library in cells
WO1998031700A1 (en) 1997-01-21 1998-07-23 The General Hospital Corporation Selection of proteins using rna-protein fusions
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
JP4093507B2 (ja) * 1997-03-10 2008-06-04 旭化成ファーマ株式会社 緩衝液組成
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
JP4086325B2 (ja) 1997-04-23 2008-05-14 プリュックテュン，アンドレアス 標的分子と相互作用する（ポリ）ペプチドをコードする核酸分子の同定方法
US7951917B1 (en) 1997-05-02 2011-05-31 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
JP4860098B2 (ja) 2000-12-18 2012-01-25 ダイアックス、コープ 遺伝的パッケージの焦点を合わせたライブラリー
US20060235208A1 (en) 2002-09-27 2006-10-19 Xencor, Inc. Fc variants with optimized properties
US20060134105A1 (en) 2004-10-21 2006-06-22 Xencor, Inc. IgG immunoglobulin variants with optimized effector function
WO2006020258A2 (en) 2004-07-17 2006-02-23 Imclone Systems Incorporated Novel tetravalent bispecific antibody
TW200714313A (en) * 2005-04-08 2007-04-16 Chugai Pharmaceutical Co Ltd Antibodies that substitute for coagulation factor VIII
EP2009101B1 (en) * 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
CN101460622A (zh) * 2006-03-31 2009-06-17 中外制药株式会社 用于纯化双特异性抗体的抗体修饰方法
CN101558310B (zh) * 2006-12-21 2013-05-08 积水医疗株式会社 含凝血酶的溶液中的α-凝血酶的稳定化方法
EP3392273A1 (en) 2007-05-30 2018-10-24 Xencor, Inc. Methods and compositions for inhibiting cd32b expressing cells
EP2197490A2 (en) 2007-08-28 2010-06-23 Biogen Idec MA, Inc. Compositions that bind multiple epitopes of igf-1r
EP2193146B1 (en) 2007-09-14 2016-05-25 Adimab, LLC Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
RU2510400C9 (ru) * 2007-09-26 2014-07-20 Чугаи Сейяку Кабусики Кайся Способ модификации изоэлектрической точки антитела с помощью аминокислотных замен в cdr
DK2235064T3 (en) 2008-01-07 2016-01-11 Amgen Inc A process for the preparation of heterodimeric Fc molecules using electrostatic control effects
WO2009110132A1 (ja) 2008-03-06 2009-09-11 富士電機ホールディングス株式会社 アクティブ・マトリクス型表示装置
EP2297209A4 (en) 2008-06-03 2012-08-01 Abbott Lab IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
SG178078A1 (en) * 2009-07-24 2012-03-29 Hoffmann La Roche Optimizing the production of antibodies
WO2011028952A1 (en) 2009-09-02 2011-03-10 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CN107337734A (zh) * 2009-12-04 2017-11-10 弗·哈夫曼-拉罗切有限公司 多特异性抗体、抗体类似物、组合物和方法
CA2796633C (en) * 2010-04-23 2020-10-27 Genentech, Inc. Production of heteromultimeric proteins
AU2011279073B2 (en) 2010-07-16 2016-06-09 Adimab, Llc Antibody libraries
EP3797847A1 (en) * 2010-07-30 2021-03-31 Medlmmune, LLC Purified active polypeptides or immunoconjugates
US10344050B2 (en) * 2011-10-27 2019-07-09 Genmab A/S Production of heterodimeric proteins
PT2825559T (pt) 2012-03-13 2019-06-07 Novimmune Sa Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativo
JP2015537212A (ja) * 2012-11-15 2015-12-24 ジェネンテック， インコーポレイテッド イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー
CN108472360B (zh) 2015-04-10 2023-01-17 阿迪马布有限责任公司 从亲代同源二聚抗体种类中纯化异源二聚多特异性抗体的方法

Similar Documents

Publication Publication Date Title
JP2018512431A5 (cg-RX-API-DMAC7.html)
Gomis‐Fons et al. Model‐based design and control of a small‐scale integrated continuous end‐to‐end mAb platform
Westermeier Reiner Westermeier, Tom Naven, and Hans-Rudolf Hçpker Proteomics in Practice
Stein et al. Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal
RU2015122726A (ru) ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
JP2015537212A5 (cg-RX-API-DMAC7.html)
Rathore et al. Scale-up and optimization in preparative chromatography
ES2988082T3 (es) Elución de biomoléculas a partir de resinas multimodales utilizando MES y MOPS como modificadores de fase móvil
JP2018516229A5 (cg-RX-API-DMAC7.html)
Trnovec et al. Characterization of membrane adsorbers used for impurity removal during the continuous purification of monoclonal antibodies
IL297116A (en) A method for purifying single-stranded RNA
RU2016104542A (ru) Осуществление оптимизации входных условий ионообменной хроматографии
Zhou et al. Large‐scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach
EP2814608B1 (en) REDUCING pH EXCURSIONS IN ION EXCHANGE CHROMATOGRAPHY
CN108350027A (zh) 用于改进的蛋白质分离的相反的pH-盐梯度
Connell‐Crowley et al. Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes
JP2016529489A5 (cg-RX-API-DMAC7.html)
Morrow Jr Advances in antibody manufacturing using mammalian cells
Che Hussian et al. Factors affecting therapeutic protein purity and yield during chromatographic purification
CN106480014B (zh) 选择性分离核酸的方法及其套组
Chen et al. Partition coefficient screening–An effective approach for finding the best conditions for byproduct removal as demonstrated by a bispecific antibody purification case
Kostelec et al. Production and Purification of mRNA
CN116829569A (zh) 蛋白质纯化缓冲液和方法
Ng et al. pH‐based cation exchange chromatography in the capture and elution of monoclonal antibodies
KR102140531B1 (ko) Gly-Tβ4의 제조방법